A diagnosis of breast cancer has taken on a new meaning in the past 10 years, as research has produced a host of new therapies and detection techniques, significantly improving long-term survival for women who have been fighting the disease. To build on these successes, researchers are now harnessing what they have learned about treating breast cancer and applying it to possible methods of prevention to reduce the total incidence of the disease. One study presented today at the American Association for Cancer Research's Frontiers in Cancer Prevention Research meeting in Boston looks at a specific target in the fight against breast cancer and evaluates a potential vaccine that is yielding promising results for women who are at high-risk for the disease.
Targeted immunoediting of critical pathways responsible for breast cancer development: treatment of early breast cancer using HER-2/neu pulsed dendritic cells
Multiple genetic targets have been discovered that may help fight breast cancer, including BRCA, estrogen receptors, and HER-2/neu, all of which have been known to predict the severity of disease, recurrence and overall survival. Developing novel therapies that target these specific genetic variances may be extremely beneficial in preventing breast cancer for many women.
In this study, researchers investigated a potential vaccine that targets HER-2/neu over-expression in early stage breast cancer, known as DCIS (ductal carcinomas in situ, or early stage cancer formation in the breast's milk ducts). It is estimated at 50-60 percent of DCIS is directly related to HER-2/neu over-expression.
Patients with HER-2/neu overexpression were given a therapy of dendritic cells (DC, which work with the B- and T-cells to trigger immune responses) that were treated with HER-2/neu to evoke an immune response. The participants received four weekly vaccinations into normal lymph nodes in their groins and were evaluated both pre- and poPage: 1 2 Related biology news :1
Source:American Association for Cancer Research
. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down2
. Novel technology detects human DNA mutations3
. Novel antiviral technology inhibits RSV infection in mice4
. Novel Enzyme Shows Potential As An Anti-HIV Target5
. Novel Therapy Tested in Mice Could Chase Away Cat Allergies6
. Discovery Could Lead To Novel Approaches In HIV Treatment7
. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells8
. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer9
. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma10
. Novel live reporting system to track cells11
. Field of beams - Novel system uses polarized light pulses to reveal crop health